148 related articles for article (PubMed ID: 28636893)
1. Controlled release from aspirin based linear biodegradable poly(anhydride esters) for anti-inflammatory activity.
Dasgupta Q; Movva S; Chatterjee K; Madras G
Int J Pharm; 2017 Aug; 528(1-2):732-740. PubMed ID: 28636893
[TBL] [Abstract][Full Text] [Related]
2. Linear, Mannitol-Based Poly(anhydride-esters) with High Ibuprofen Loading and Anti-Inflammatory Activity.
Stebbins ND; Yu W; Uhrich KE
Biomacromolecules; 2015 Nov; 16(11):3632-9. PubMed ID: 26450447
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and degradation characteristics of salicylic acid-derived poly(anhydride-esters).
Erdmann L; Uhrich KE
Biomaterials; 2000 Oct; 21(19):1941-6. PubMed ID: 10941915
[TBL] [Abstract][Full Text] [Related]
4. Characterization of internal structure, polymer erosion and drug release mechanisms of biodegradable poly(ester anhydride)s by X-ray microtomography.
Mönkäre J; Pajander J; Hakala RA; Savolainen P; Järveläinen M; Korhonen H; Seppälä JV; Järvinen K
Eur J Pharm Sci; 2012 Aug; 47(1):170-8. PubMed ID: 22683891
[TBL] [Abstract][Full Text] [Related]
5. Poly(ortho ester) biodegradable polymer systems.
Heller J; Himmelstein KJ
Methods Enzymol; 1985; 112():422-36. PubMed ID: 3930918
[TBL] [Abstract][Full Text] [Related]
6. Poly(ester-anhydrides) Derived from Esters of Hydroxy Acid and Cyclic Anhydrides.
Arun Y; Ghosh R; Domb AJ
Biomacromolecules; 2022 Aug; 23(8):3417-3428. PubMed ID: 35881559
[TBL] [Abstract][Full Text] [Related]
7. Poly(anhydride-ester) gemcitabine: Synthesis and particle engineering of a high payload hydrolysable polymeric drug for cancer therapy.
Heyder RS; Sunbul FS; Almuqbil RM; Fines CB; da Rocha SRP
J Control Release; 2021 Feb; 330():1178-1190. PubMed ID: 33212118
[TBL] [Abstract][Full Text] [Related]
8. Controlled protein delivery from biodegradable tyrosine-containing poly(anhydride-co-imide) microspheres.
Chiba M; Hanes J; Langer R
Biomaterials; 1997 Jul; 18(13):893-901. PubMed ID: 9199758
[TBL] [Abstract][Full Text] [Related]
9. Photocrosslinked poly(ester anhydride)s for peptide delivery: Effect of oligomer hydrophobicity on PYY3-36 delivery.
Mönkäre J; Hakala RA; Kovalainen M; Korhonen H; Herzig KH; Seppälä JV; Järvinen K
Eur J Pharm Biopharm; 2012 Jan; 80(1):33-8. PubMed ID: 21964317
[TBL] [Abstract][Full Text] [Related]
10. Alternating Poly(ester-anhydride) by Insertion Polycondensation.
Haim-Zada M; Basu A; Hagigit T; Schlinger R; Grishko M; Kraminsky A; Hanuka E; Domb AJ
Biomacromolecules; 2016 Jun; 17(6):2253-9. PubMed ID: 27198864
[TBL] [Abstract][Full Text] [Related]
11. Stable polyanhydride synthesized from sebacic acid and ricinoleic acid.
Haim-Zada M; Basu A; Hagigit T; Schlinger R; Grishko M; Kraminsky A; Hanuka E; Domb AJ
J Control Release; 2017 Jul; 257():156-162. PubMed ID: 27126904
[TBL] [Abstract][Full Text] [Related]
12. In vitro release of model compounds with different hydrophilicity from poly(ester-anhydride) microspheres.
Jaszcz K
Acta Pol Pharm; 2013; 70(6):1051-63. PubMed ID: 24383329
[TBL] [Abstract][Full Text] [Related]
13. Biocompatible photocrosslinked poly(ester anhydride) based on functionalized poly(epsilon-caprolactone) prepolymer shows surface erosion controlled drug release in vitro and in vivo.
Mönkäre J; Hakala RA; Vlasova MA; Huotari A; Kilpeläinen M; Kiviniemi A; Meretoja V; Herzig KH; Korhonen H; Seppälä JV; Järvinen K
J Control Release; 2010 Sep; 146(3):349-55. PubMed ID: 20558218
[TBL] [Abstract][Full Text] [Related]
14. Poly(anhydride-ester) and poly(N-vinyl-2-pyrrolidone) blends: salicylic acid-releasing blends with hydrogel-like properties that reduce inflammation.
Ouimet MA; Fogaça R; Snyder SS; Sathaye S; Catalani LH; Pochan DJ; Uhrich KE
Macromol Biosci; 2015 Mar; 15(3):342-50. PubMed ID: 25333420
[TBL] [Abstract][Full Text] [Related]
15. Controlled release kinetics of p-aminosalicylic acid from biodegradable crosslinked polyesters for enhanced anti-mycobacterial activity.
Dasgupta Q; Madras G; Chatterjee K
Acta Biomater; 2016 Jan; 30():168-176. PubMed ID: 26596566
[TBL] [Abstract][Full Text] [Related]
16. Degradation and drug delivery properties of poly(1,4-cyclohexanedicarboxylic anhydride).
Zhang T; Gu M; Yu X
J Biomater Sci Polym Ed; 2001; 12(5):491-501. PubMed ID: 11469780
[TBL] [Abstract][Full Text] [Related]
17. Effect of drug type on the degradation rate of PLGA matrices.
Siegel SJ; Kahn JB; Metzger K; Winey KI; Werner K; Dan N
Eur J Pharm Biopharm; 2006 Nov; 64(3):287-93. PubMed ID: 16949804
[TBL] [Abstract][Full Text] [Related]
18. Polyanhydrides. V. Branched polyanhydrides.
Maniar M; Xie XD; Domb AJ
Biomaterials; 1990 Nov; 11(9):690-4. PubMed ID: 2090304
[TBL] [Abstract][Full Text] [Related]
19. Tunable drug release profiles from salicylate-based poly(anhydride-ester) matrices using small molecule admixtures.
Ouimet MA; Snyder SS; Uhrich KE
J Bioact Compat Polym; 2012 Nov; 27(6):540-549. PubMed ID: 24078768
[TBL] [Abstract][Full Text] [Related]
20. Biodegradable ferulic acid-containing poly(anhydride-ester): degradation products with controlled release and sustained antioxidant activity.
Ouimet MA; Griffin J; Carbone-Howell AL; Wu WH; Stebbins ND; Di R; Uhrich KE
Biomacromolecules; 2013 Mar; 14(3):854-61. PubMed ID: 23327626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
